Healthcare
Medical community struggles over how to help patients with long-lasting, serious side effects even after “recovering” from COVID-19 infection.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 2, 2021.
A research team from Brigham and Women’s Hospital has discovered an astrocyte sub-population that serves an anti-inflammatory function in the brain based on signals regulated by gut bacteria.
The U.S. Department of Justice is set to recover more than $3 billion this year from pharmaceutical and medical device manufacturers as well as healthcare providers, labs and pharmacies found guilty of healthcare fraud under the False Claims Act.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
If you know Roivant as a brand you might be familiar with Vivek Ramaswamy too. Recently, he stepped down as CEO and became Executive Chairman. Let’s know more.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
n-Lorem Foundation has taken on a challenge that many nations consider too great: treating patients with ultra-rare diseases (which affect 30 or fewer people) for free, for life.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
Although they don’t necessarily agree on numbers, most reports indicate that 2020 was not a particularly good year for mergers and acquisitions in the biopharma industry.
PRESS RELEASES